Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dal Lago

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Geriatric Medicine|October 23, 2024
Survey on current clinical practice in geriatric oncology: the individual experience in five European Cancer CentersM Javier-González, R Boulahssass, L Dal Lago, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1996
Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective studyT Ranzi, P Bodini, A Zambelli, et al.
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.
Journal of Geriatric Oncology|November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancerChantal Quinten, C Kenis, M Hamaker, et al.
ESMO Open|March 27, 2026
The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancerC Baldini, A R A Mislang, K-L Cheung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2017
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramF Cardoso, J M S Bartlett, L Slaets, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Geriatric Medicine|October 23, 2024
Survey on current clinical practice in geriatric oncology: the individual experience in five European Cancer CentersM Javier-González, R Boulahssass, L Dal Lago, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1996
Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective studyT Ranzi, P Bodini, A Zambelli, et al.
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.
Journal of Geriatric Oncology|November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancerChantal Quinten, C Kenis, M Hamaker, et al.
ESMO Open|March 27, 2026
The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancerC Baldini, A R A Mislang, K-L Cheung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2017
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramF Cardoso, J M S Bartlett, L Slaets, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Pageof 1